Health CarePharmaceuticals & Biotechnology
  • Price (USD)84.25
  • Today's Change-0.06 / -0.07%
  • Shares traded6.93m
  • 1 Year change10.19%
  • Beta0.6756
Data delayed at least 15 minutes, as of Oct 20 2020 21:10 BST.
More ▼

Key statistics

On Tuesday, Abbvie Inc (ABBV:NYQ) closed at 84.25, -16.81% below its 52-week high of 101.28, set on Jul 17, 2020.
52-week range
62.55Mar 23 2020101.28Jul 17 2020
Markit short selling activity
Previous close84.25
Average volume6.91m
Shares outstanding1.76bn
Free float1.76bn
P/E (TTM)18.53
Market cap148.69bn USD
EPS (TTM)4.55
Annual div (ADY)4.72
Annual div yield (ADY)5.60%
Div ex-dateOct 14 2020
Div pay-dateNov 16 2020
Data delayed at least 15 minutes, as of Oct 20 2020 21:10 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.